In vitro diagnostics are tests that can detect diseases, conditions, or infections. In vitro diagnostics provide valuable information regarding the physiological and/or pathological state of body and therefore, they are very essential to take well-informed medical decisions.
The growth drivers of In Vitro Diagnostic market are increasing incidence of chronic and infectious diseases, aging population, and rise in point of testing. However lack of budget is restraint of the market.
This report categorizes the In Vitro Diagnostic market by technology, by applications, by product types, and by end users. The oncology diagnostics market is the fastest increasing fragment in vitro diagnostic applications. Major players such as Roche Diagnostics, Siemens Healthcare, and Hologic are continuously launching new In Vitro Diagnostics products for the detection of cancer. In addition, point-of-care (POC) testing is also gaining fame and is poised to grow at a high single-digit CAGR in the coming years.
This research report provides comprehensive analysis of In Vitro Diagnostic market across the globe. The geographical regions covered in this report are North America (U.S, Canada), Europe (Germany, France, Italy, U.K, Spain), Asia- pacific (Japan, India, Chain) and rest of world (Latin America, Middle East Africa).
The report meticulously analyzes the In Vitro Diagnostic market by following categories
Market by Technology
• Clinical chemistry
• Molecular diagnostic
Market by Product Type
Market by Applications
• Infectious disease
• Autoimmune disease
• Drug testing
Market by End users
• Point of testing
• Patient self testing
Source: Expert Interviews, Government Authorities, Related associations/Institutes, Related Research Publication, Government Publication, Company Press Release, Company Annual Reports, Company Website, Company Publication, SEC Filings, Meticulous Analysis.